Back to the stock market, I wanted to relay an email I got from a valued subscriber just this week: “A number of weeks back I purchased Thoratec (THOR) after reading about it in Cabot Market Letter. I missed the trigger to sell my shares when it dropped below 20% of its purchase price, and it continued down to nearly 30% below. When it popped just before Thanksgiving the stock was at 14% below purchase price and I took the opportunity to sell my shares. Over Thanksgiving break it was added to the S&P 500 Midcap index, and on...
